Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

A new era of anticoagulation treatment: optimizing outcomes for atrial fibrillation.

Ciervo CA, Granger CB, Schaller FA, Engelke KA.

J Am Osteopath Assoc. 2012 Sep;112(9 Suppl 2):eS9-21.

PMID:
23014815
2.
3.

Ischemic stroke on optimal anticoagulation with novel-oral anticoagulants compared with warfarin.

Kim BJ, Kang HG, Lee DH, Kang DW, Kim JS, Kwon SU.

Int J Stroke. 2015 Aug;10(6):E68. doi: 10.1111/ijs.12587. No abstract available.

PMID:
26202718
4.

Is warfarin still underused in patients with atrial fibrillation? A major threat to treatment benefit.

Baysan O, Yokusoglu M, Bugan B.

Int J Cardiol. 2010 Oct 29;144(3):439-40. doi: 10.1016/j.ijcard.2009.03.073. Epub 2009 Apr 5.

PMID:
19346015
5.

Atrial fibrillation and stroke prevention.

Kakar P, Lip GY.

Expert Rev Neurother. 2006 Oct;6(10):1523-30. Review.

PMID:
17078791
6.

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.

[No authors listed]

Arch Intern Med. 1994 Jul 11;154(13):1449-57. Erratum in: Arch Intern Med 1994 Oct 10;154(19):2254.

PMID:
8018000
9.

Anticoagulation control in atrial fibrillation: optimizing risks and benefits.

Alsheikh-Ali AA, Estes NA 3rd.

Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):72-3. doi: 10.1161/CIRCOUTCOMES.108.827329. No abstract available.

10.

Promise of factor Xa inhibition in atrial fibrillation.

Al-Khatib SM, Alexander JH, Lopes RD, Mahaffey KW, Patel MR, Granger CB.

Curr Cardiol Rep. 2012 Feb;14(1):70-8. doi: 10.1007/s11886-011-0230-1. Review.

PMID:
22109539
11.

Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy.

Partington SL, Abid S, Teo K, Oczkowski W, O'Donnell MJ.

Thromb Res. 2007;120(5):663-9. Epub 2007 Apr 16.

PMID:
17434577
12.

Stroke prevention in atrial fibrillation: current anticoagulation management and future directions.

Fitzgerald BT, Cohn SL, Klein AL.

Cleve Clin J Med. 2005 Apr;72 Suppl 1:S24-30. Review.

PMID:
15853176
13.

Stroke prevention in elderly patients with atrial fibrillation.

Lew SJ, Lim JK.

Singapore Med J. 2002 Apr;43(4):198-201.

PMID:
12188065
14.

Differential use of warfarin for secondary stroke prevention in patients with various types of atrial fibrillation.

Lewis WR, Fonarow GC, LaBresh KA, Cannon CP, Pan W, Super DM, Sorof SA, Schwamm LH.

Am J Cardiol. 2009 Jan 15;103(2):227-31. doi: 10.1016/j.amjcard.2008.08.062. Epub 2008 Nov 7.

15.

Prevention of stroke in patients with atrial fibrillation.

Olsson SB, Halperin JL.

Semin Vasc Med. 2005 Aug;5(3):285-92. Review.

PMID:
16123916
16.
17.

New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs.

Garcia DA, Lopes RD, Hylek EM.

Thromb Haemost. 2010 Dec;104(6):1099-105. doi: 10.1160/TH10-07-0491. Epub 2010 Sep 30. Review.

PMID:
20886196
18.

Anticoagulation therapy for patients with non-valvular atrial fibrillation: comparison of decision analytic model recommendations and real-world warfarin prescription use.

Casciano JP, Singer DE, Kwong WJ, Fox ES, Martin BC.

Am J Cardiovasc Drugs. 2012 Oct 1;12(5):313-23. doi: 10.2165/11634150-000000000-00000.

PMID:
22920047
19.
Items per page

Supplemental Content

Write to the Help Desk